Letters to the Editor
Obesity and adipose tissue cytokines in rheumatoid arthritis treated with IL-6 inhibitors: does the route of administration matter?
M. Novella-Navarro1, F. Genre2, A. Martínez-Feito3, V. Pulito-Cueto4, C. Plasencia-Rodríguez5, A. Balsa6
- Rheumatology Department, Hospital Universitario La Paz, Madrid, and Inmuno-Rheumatology Research Group, Hospital La Paz, Institute for Health Research - IdiPAZ, Madrid, Spain. mnovellanavarro@gmail.com
- Research Group on Genetic Epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic Diseases of the Musculoskeletal System, IDIVAL, Hospital Universitario Marqués de Valdecilla, Santander, Spain.
- Immunology Unit, Inmuno-Rheumatology Research Group, Hospital La Paz, Institute for Health Research - IdiPAZ, Madrid, Spain.
- Research Group on Genetic Epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic Diseases of the Musculoskeletal System, IDIVAL, Hospital Universitario Marqués de Valdecilla, Santander, Spain.
- Rheumatology Department, Hospital Universitario La Paz, Madrid, and Inmuno-Rheumatology Research Group, Hospital La Paz, Institute for Health Research - IdiPAZ, Madrid, Spain.
- Rheumatology Department, Hospital Universitario La Paz, Madrid, and Inmuno-Rheumatology Research Group, Hospital La Paz, Institute for Health Research - IdiPAZ, Madrid, Spain.
CER16536
2023 Vol.41, N°7
PI 1563, PF 1564
Letters to the Editor
Free to view
(click on article PDF icon to read the article)
PMID: 37140684 [PubMed]
Received: 24/01/2023
Accepted : 20/03/2023
In Press: 03/05/2023
Published: 10/07/2023
